… for antiviral therapies and vaccines to treat and prevent COVID-19. In this review, we provide
an overview of SARS-CoV-2 and discuss the emerging therapies and vaccines that show …

… vaccine studies revealed human clinical safety risks related to ADE, resulting in failed vaccine
… discuss mitigation strategies for SARS-CoV-2 vaccines and therapies in development. We …

… underlying SARS-CoV-2 … therapies, and nucleic acid vaccines showing promise. This
review discusses the advances in the immunopathology of SARS-CoV-2, vaccines and therapies …

… The causative coronavirus SARS-CoV-2 effortlessly spread across the world for almost a year
with only minimal changes to its RNA genome. However, just as … Vaccines and mAbs …

… However, we also estimate that protecting vulnerable individuals by ensuring accessibility
to vaccines and antiviral therapies, and maintaining implementation of nonpharmaceutical …

… dose of mRNA-based vaccines exhibited substantially … vaccines and therapies, compelling
the development of new interventions that anticipate the evolutionary trajectory of SARS-CoV…

… Currently, there are no potent effective antiviral therapies available for SARS-CoV-2 [19].
Nonetheless, the United States Food and Drug Administration (US FDA) approvals have sped …

… This Review will describe how each of the vaccines, antibody therapies, and antiviral drugs
that have been approved to date were built on decades of investment in technology and …

… Here we review the mutational landscape on the SARS-CoV-2 structural and non-structural …
and vaccines. We also look at the effectiveness of approved vaccines, antibody therapy and …

… vaccines as promising alternatives to conventional vaccine approaches, while the development
of effective antiviral therapies for treating SARS-CoV-… the effect of SARS-CoV-2 infection …